2 transcripts
MLYS
Earnings call transcript
NASDAQ
2024 Q1
9 May 24
for potential inclusion in the hypertension guidelines for treating physicians and forward creating favorable access via payers.
As you may be aware
MLYS
Earnings call transcript
NASDAQ
2023 Q4
21 Mar 24
the data package of lorundrostat. We believe access aldosterone is common and is a significant contributor in approximately 25% of all hypertension patients
- Prev
- 1
- Next